Table 2.
Hazard ratios of hospitalization for cardiovascular disease in patients treated with DPP-4 inhibitors versus glimepiride.
Hazard ratios of hospitalization for cardiovascular disease in patients treated with DPP-4 inhibitors versus glimepiride.